Company News, New Products

Merz Strikes Deal With Brickell Biotech

Will develop retinoid for sensitive skin.

Merz North America inked a new licensing agreement with Brickell Biotech, Inc. for the development of a novel retinoid compound for the treatment of skin conditions known to be responsive to retinoid agents, such as acne and psoriasis.  Under this agreement Merz will have an exclusive North American license, with certain additional international rights, to develop and commercialize this compound.   The development of this retinoid product will be a key milestone as Merz Dermatology works to expa...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters